Mallinckrodt sues Mylan over fever drug patent

02-12-2016

Mallinckrodt sues Mylan over fever drug patent

tonefotografia / shutterstock.com

Pharmaceutical company Mallinckrodt has filed a complaint against Mylan for alleged patent infringement over its drug Ofirmev (acetaminophen), a treatment for fever.


Mallinckrodt, Mylan, Ofirmev, patent, NDA, FDA

LSIPR